Thomas DL - Search Results

1

Hepatitis C pharmacogenetics: state of the art in 2010.

Afdhal NH, McHutchison JG, Zeuzem S, Mangia A, Pawlotsky JM, Murray JS, Shianna KV, Tanaka Y, Thomas DL, Booth DR, Goldstein DB; Pharmacogenetics and Hepatitis C Meeting Participants. Afdhal NH, et al. Among authors: thomas dl. Hepatology. 2011 Jan;53(1):336-45. doi: 10.1002/hep.24052. Hepatology. 2011. PMID: 21254181 Review.

2

Severity and correlates of liver disease in hepatitis C virus-infected injection drug users.

Rai R, Wilson LE, Astemborski J, Anania F, Torbenson M, Spoler C, Vlahov D, Strathdee SA, Boitnott J, Nelson KE, Thomas DL. Rai R, et al. Among authors: thomas dl. Hepatology. 2002 May;35(5):1247-55. doi: 10.1053/jhep.2002.33151. Hepatology. 2002. PMID: 11981775

3

Diagnosis, management, and treatment of hepatitis C.

Strader DB, Wright T, Thomas DL, Seeff LB; American Association for the Study of Liver Diseases. Strader DB, et al. Among authors: thomas dl. Hepatology. 2004 Apr;39(4):1147-71. doi: 10.1002/hep.20119. Hepatology. 2004. PMID: 15057920 No abstract available.

4

Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus.

Sulkowski MS, Mehta SH, Torbenson M, Afdhal NH, Mirel L, Moore RD, Thomas DL. Sulkowski MS, et al. Among authors: thomas dl. AIDS. 2005 Mar 24;19(6):585-92. doi: 10.1097/01.aids.0000163935.99401.25. AIDS. 2005. PMID: 15802977

5

Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index.

Kelleher TB, Mehta SH, Bhaskar R, Sulkowski M, Astemborski J, Thomas DL, Moore RE, Afdhal NH. Kelleher TB, et al. Among authors: thomas dl. J Hepatol. 2005 Jul;43(1):78-84. doi: 10.1016/j.jhep.2005.02.025. Epub 2005 Apr 25. J Hepatol. 2005. PMID: 15894397

6

Progression of liver fibrosis among injection drug users with chronic hepatitis C.

Wilson LE, Torbenson M, Astemborski J, Faruki H, Spoler C, Rai R, Mehta S, Kirk GD, Nelson K, Afdhal N, Thomas DL. Wilson LE, et al. Among authors: thomas dl. Hepatology. 2006 Apr;43(4):788-95. doi: 10.1002/hep.21091. Hepatology. 2006. PMID: 16557548

7

Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults.

Sulkowski MS, Mehta SH, Torbenson MS, Higgins Y, Brinkley SC, de Oca RM, Moore RD, Afdhal NH, Thomas DL. Sulkowski MS, et al. Among authors: thomas dl. AIDS. 2007 Oct 18;21(16):2209-16. doi: 10.1097/QAD.0b013e3282f10de9. AIDS. 2007. PMID: 18090048

8

Exceeding the limits of liver histology markers.

Mehta SH, Lau B, Afdhal NH, Thomas DL. Mehta SH, et al. Among authors: thomas dl. J Hepatol. 2009 Jan;50(1):36-41. doi: 10.1016/j.jhep.2008.07.039. Epub 2008 Oct 18. J Hepatol. 2009. PMID: 19012989 Free PMC article.

9

SAFE biopsy: a validated method for large-scale staging of liver fibrosis in chronic hepatitis C.

Sebastiani G, Halfon P, Castera L, Pol S, Thomas DL, Mangia A, Di Marco V, Pirisi M, Voiculescu M, Guido M, Bourliere M, Noventa F, Alberti A. Sebastiani G, et al. Among authors: thomas dl. Hepatology. 2009 Jun;49(6):1821-7. doi: 10.1002/hep.22859. Hepatology. 2009. PMID: 19291784

10

Diagnosis, management, and treatment of hepatitis C: an update.

Ghany MG, Strader DB, Thomas DL, Seeff LB; American Association for the Study of Liver Diseases. Ghany MG, et al. Among authors: thomas dl. Hepatology. 2009 Apr;49(4):1335-74. doi: 10.1002/hep.22759. Hepatology. 2009. PMID: 19330875 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

751 results

Search Page